Sino Biopharmaceutical | 1177 - Spese Di Vendita E Di Amministrazione





Spese Di Vendita E Di Amministrazione Cambiamento Data
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 447K 138K 2026-03
Avita Medical AUD 19.03M 1.95M 2025-12
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Ionis Pharmaceuticals USD 151M 21M 2026-03
IQVIA Holdings USD 502M 34M 2026-03
Jiangsu Hengrui CNY 2.81B 191.05M 2026-03
Moderna USD 173M 135M 2026-03
Organon & Co USD 424M 9M 2026-03
Revvity USD 253.88M 2.15M 2026-03
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Tectonic Therapeutic USD 6.43M 2.99M 2026-03
Viatris USD 928.8M 101.9M 2026-03
Xeris Pharmaceuticals USD 53.14M 10.51M 2026-03